CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 159 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $17,183,000 | +1895.7% | 508,375 | +1281.5% | 0.01% | – |
| Q1 2021 | $861,000 | -76.7% | 36,800 | -71.3% | 0.00% | -100.0% |
| Q4 2020 | $3,697,000 | +96.3% | 128,358 | +38.1% | 0.00% | +100.0% |
| Q3 2020 | $1,883,000 | -32.9% | 92,941 | -0.4% | 0.00% | -50.0% |
| Q2 2020 | $2,805,000 | +7.4% | 93,337 | +12.3% | 0.00% | 0.0% |
| Q1 2020 | $2,612,000 | +204.8% | 83,113 | +356.7% | 0.00% | – |
| Q4 2019 | $857,000 | – | 18,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |